BioNTech Investor Förtsch Demands Oversight of Founders' Spinout and Asset Transfer Deal
Updated
Updated · Bloomberg · Jun 17
BioNTech Investor Förtsch Demands Oversight of Founders' Spinout and Asset Transfer Deal
1 articles · Updated · Bloomberg · Jun 17
Summary
Bernd Förtsch on Wednesday pressed BioNTech to disclose more about its founders’ planned departure and the transfer of assets to their new venture.
The investor said the setup of a new company, along with the planned movement of expertise and personnel, raises serious corporate-governance concerns.
His intervention puts fresh scrutiny on how BioNTech manages the spinout process, especially any shift of know-how, staff and other resources to the founders’ venture.